| |
| |
|
| Insider
Information: |
Siebert John M |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
589,640 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,450,971 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
589,640 |
|
|
| Total
Value |
$2,450,971 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aradigm Corp |
ARDM |
Director |
2013-05-22 |
501,697 |
|
0 |
Premium* |
|
|
Supernus Pharmaceuticals Inc |
SUPN |
Director |
2024-02-23 |
87,943 |
2012-05-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SUPN |
Supernus Pharmaceuticals ... |
Director |
– • – |
2024-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,886 |
87,943 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Director |
– • – |
2023-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
3,882 |
84,057 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Director |
– • – |
2022-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
4,222 |
80,175 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Director |
– • – |
2021-08-11 |
4 |
OE |
$12.98 |
$194,700 |
D/D |
15,000 |
75,953 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Director |
– • – |
2020-02-21 |
4 |
A |
$23.99 |
$125,012 |
D/D |
5,211 |
60,953 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Director |
– • – |
2019-06-20 |
4 |
OE |
$9.13 |
$91,300 |
D/D |
10,000 |
55,742 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Director |
– • – |
2019-04-25 |
4 |
OE |
$9.13 |
$91,300 |
D/D |
10,000 |
45,742 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Director |
– • – |
2018-08-20 |
4 |
OE |
$7.90 |
$137,806 |
D/D |
16,179 |
35,742 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Director |
– • – |
2014-12-16 |
4 |
OE |
$4.24 |
$9,277 |
D/D |
2,188 |
19,563 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Director |
– • – |
2013-12-12 |
4 |
OE |
$4.24 |
$9,273 |
D/D |
2,187 |
17,375 |
0 |
- |
|
| ARDM |
Aradigm Corp |
Director |
– • – |
2013-05-22 |
4 |
A |
$0.15 |
$15,000 |
D/D |
100,000 |
501,697 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Director |
– • – |
2013-03-21 |
4 |
B |
$5.50 |
$16,500 |
D/D |
3,000 |
15,188 |
2.39 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Director |
– • – |
2012-12-14 |
4 |
OE |
$4.24 |
$9,277 |
D/D |
2,188 |
12,188 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Director |
– • – |
2012-12-04 |
4 |
B |
$8.14 |
$56,980 |
D/D |
7,000 |
10,000 |
2.39 |
- |
|
| ARDM |
Aradigm Corp |
Director |
– • – |
2012-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
401,697 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Director |
– • – |
2012-05-04 |
4 |
B |
$5.00 |
$15,000 |
D/D |
3,000 |
3,000 |
2.39 |
- |
|
| ARDM |
Aradigm Corp |
Director |
– • – |
2011-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
78,947 |
301,697 |
0 |
- |
|
| ARDM |
Aradigm Corp |
Director |
– • – |
2010-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
222,750 |
0 |
- |
|
| ARDM |
Aradigm Corp |
Director |
– • – |
2009-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
93,750 |
97,750 |
0 |
- |
|
| ARDM |
Aradigm Corp |
Director |
– • – |
2006-11-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,000 |
|
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
